loading

Nrx Pharmaceuticals Inc Azioni (NRXP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Income/Loss From Continuing Operations Before Tax
30.20%
-5.512
-7.897 -6.528 -4.332 -6.062
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
30.20%
-5.512
-7.897 -6.528 -4.332 -6.062
Net Income/Loss
30.20%
-5.512
-7.897 -6.528 -4.332 -6.062
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):